Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Capital Expenditures: 2012-2024

Historic Capital Expenditures for Neurogene (NGNE) over the last 13 years, with Dec 2024 value amounting to $808,000.

  • Neurogene's Capital Expenditures fell 28.65% to $127,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 39.59%. This contributed to the annual value of $808,000 for FY2024, which is 151.71% up from last year.
  • According to the latest figures from FY2024, Neurogene's Capital Expenditures is $808,000, which was up 151.71% from $321,000 recorded in FY2023.
  • In the past 5 years, Neurogene's Capital Expenditures ranged from a high of $3.3 million in FY2021 and a low of $321,000 during FY2023.
  • For the 3-year period, Neurogene's Capital Expenditures averaged around $1.1 million, with its median value being $808,000 (2024).
  • Per our database at Business Quant, Neurogene's Capital Expenditures spiked by 152.45% in 2020 and then crashed by 85.61% in 2023.
  • Yearly analysis of 5 years shows Neurogene's Capital Expenditures stood at $2.2 million in 2020, then surged by 47.05% to $3.3 million in 2021, then crashed by 31.66% to $2.2 million in 2022, then plummeted by 85.61% to $321,000 in 2023, then skyrocketed by 151.71% to $808,000 in 2024.